{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Custirsen_Sodium",
  "nciThesaurus": {
    "casRegistry": "685922-56-9",
    "chebiId": "",
    "chemicalFormula": "C231H292N78O119P20S20.20Na",
    "definition": "The eicosasodium salt of a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties. Custirsen inhibits testosterone-repressed prostate message-2 (TRPM-2). Administration of custirsen abrogates the anti-apoptotic effect of TRPM-2, thereby sensitizing cells to chemotherapy and resulting in tumor cell death. TRPM-2 is an anti-apoptotic clusterin that is overexpressed by prostate cancer cells and is associated with chemoresistance.",
    "fdaUniiCode": "ILE26V76EB",
    "identifier": "C1055",
    "preferredName": "Custirsen Sodium",
    "semanticType": "Nucleic Acid, Nucleoside, or Nucleotide",
    "subclassOf": [
      "C1291"
    ],
    "synonyms": [
      "(3'-5')d(P-thio)([2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-A-G-C-A-G-A-G-T-C-T-T-C-A-[2'-O-(2- methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]m5rU), Eicosasodium Salt",
      "Antisense TRPM-2",
      "Antisense Testosterone-Repressed Prostate Message 2",
      "CUSTIRSEN SODIUM",
      "Clusterin Antisense Oligonucleotide",
      "Custirsen Sodium",
      "ISIS 112989",
      "OGX-011",
      "TRPM-2 Antisense",
      "custirsen sodium"
    ]
  }
}